The use of SCID mice for the growth of retinoblastoma cell lines and for the establishment of xenografts from primary tumours

John Kenneth Cowell, P. Ramani, Y. Song, M. Evans, G. Morgan

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We investigated the possibility of growing primary retinoblastoma tumour tissue in SCID mice. In preliminary experiments with the WERI retinoblastoma cell line injected subcutaneously in SCID mice, tumours arose at only 25% of the inoculation sites. After mixing these cells with a reconstituted basement membrane extracellular matrix (Matrigel) prior to inoculation, tumours arose at 100% of inoculated sites. When primary retinoblastoma cells were injected subcutaneously into SCID mice in the presence of Matrigel, tumours arose in 5/8 cases. On average, the latency period was 4 months before the tumours were palpable. Histopathological examination of the tumours showed that they resembled surgically resected human retinoblastomas and one of the tumours formed pseudo-rosettes which is a characteristic of these tumours. Unfortunately, when these xenografted tumours were introduced into tissue culture, it was not possible to establish cell lines directly and the cultures were soon overgrown by mouse cells which could clearly be shown to be infiltrating the tumour. The ability to grow retinoblastoma cell lines and primary tissue subcutaneously in SCID mice offers a convenient model system to study the genetics of tumorigenesis in this tumour type and possibly an opportunity to study the role of chemotherapy in the treatment and progression of the disease.

Original languageEnglish (US)
Pages (from-to)1070-1074
Number of pages5
JournalEuropean Journal of Cancer Part A
Volume33
Issue number7
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

SCID Mice
Retinoblastoma
Heterografts
Cell Line
Growth
Neoplasms
Basement Membrane
Extracellular Matrix
Disease Progression
Carcinogenesis

Keywords

  • In vivo growth
  • Matrigel
  • Retinoblastoma
  • SCID mice

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The use of SCID mice for the growth of retinoblastoma cell lines and for the establishment of xenografts from primary tumours. / Cowell, John Kenneth; Ramani, P.; Song, Y.; Evans, M.; Morgan, G.

In: European Journal of Cancer Part A, Vol. 33, No. 7, 01.01.1997, p. 1070-1074.

Research output: Contribution to journalArticle

@article{81b24fb3343e40af941226437168bc0a,
title = "The use of SCID mice for the growth of retinoblastoma cell lines and for the establishment of xenografts from primary tumours",
abstract = "We investigated the possibility of growing primary retinoblastoma tumour tissue in SCID mice. In preliminary experiments with the WERI retinoblastoma cell line injected subcutaneously in SCID mice, tumours arose at only 25{\%} of the inoculation sites. After mixing these cells with a reconstituted basement membrane extracellular matrix (Matrigel) prior to inoculation, tumours arose at 100{\%} of inoculated sites. When primary retinoblastoma cells were injected subcutaneously into SCID mice in the presence of Matrigel, tumours arose in 5/8 cases. On average, the latency period was 4 months before the tumours were palpable. Histopathological examination of the tumours showed that they resembled surgically resected human retinoblastomas and one of the tumours formed pseudo-rosettes which is a characteristic of these tumours. Unfortunately, when these xenografted tumours were introduced into tissue culture, it was not possible to establish cell lines directly and the cultures were soon overgrown by mouse cells which could clearly be shown to be infiltrating the tumour. The ability to grow retinoblastoma cell lines and primary tissue subcutaneously in SCID mice offers a convenient model system to study the genetics of tumorigenesis in this tumour type and possibly an opportunity to study the role of chemotherapy in the treatment and progression of the disease.",
keywords = "In vivo growth, Matrigel, Retinoblastoma, SCID mice",
author = "Cowell, {John Kenneth} and P. Ramani and Y. Song and M. Evans and G. Morgan",
year = "1997",
month = "1",
day = "1",
doi = "10.1016/S0959-8049(97)88064-1",
language = "English (US)",
volume = "33",
pages = "1070--1074",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - The use of SCID mice for the growth of retinoblastoma cell lines and for the establishment of xenografts from primary tumours

AU - Cowell, John Kenneth

AU - Ramani, P.

AU - Song, Y.

AU - Evans, M.

AU - Morgan, G.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - We investigated the possibility of growing primary retinoblastoma tumour tissue in SCID mice. In preliminary experiments with the WERI retinoblastoma cell line injected subcutaneously in SCID mice, tumours arose at only 25% of the inoculation sites. After mixing these cells with a reconstituted basement membrane extracellular matrix (Matrigel) prior to inoculation, tumours arose at 100% of inoculated sites. When primary retinoblastoma cells were injected subcutaneously into SCID mice in the presence of Matrigel, tumours arose in 5/8 cases. On average, the latency period was 4 months before the tumours were palpable. Histopathological examination of the tumours showed that they resembled surgically resected human retinoblastomas and one of the tumours formed pseudo-rosettes which is a characteristic of these tumours. Unfortunately, when these xenografted tumours were introduced into tissue culture, it was not possible to establish cell lines directly and the cultures were soon overgrown by mouse cells which could clearly be shown to be infiltrating the tumour. The ability to grow retinoblastoma cell lines and primary tissue subcutaneously in SCID mice offers a convenient model system to study the genetics of tumorigenesis in this tumour type and possibly an opportunity to study the role of chemotherapy in the treatment and progression of the disease.

AB - We investigated the possibility of growing primary retinoblastoma tumour tissue in SCID mice. In preliminary experiments with the WERI retinoblastoma cell line injected subcutaneously in SCID mice, tumours arose at only 25% of the inoculation sites. After mixing these cells with a reconstituted basement membrane extracellular matrix (Matrigel) prior to inoculation, tumours arose at 100% of inoculated sites. When primary retinoblastoma cells were injected subcutaneously into SCID mice in the presence of Matrigel, tumours arose in 5/8 cases. On average, the latency period was 4 months before the tumours were palpable. Histopathological examination of the tumours showed that they resembled surgically resected human retinoblastomas and one of the tumours formed pseudo-rosettes which is a characteristic of these tumours. Unfortunately, when these xenografted tumours were introduced into tissue culture, it was not possible to establish cell lines directly and the cultures were soon overgrown by mouse cells which could clearly be shown to be infiltrating the tumour. The ability to grow retinoblastoma cell lines and primary tissue subcutaneously in SCID mice offers a convenient model system to study the genetics of tumorigenesis in this tumour type and possibly an opportunity to study the role of chemotherapy in the treatment and progression of the disease.

KW - In vivo growth

KW - Matrigel

KW - Retinoblastoma

KW - SCID mice

UR - http://www.scopus.com/inward/record.url?scp=0030759657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030759657&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(97)88064-1

DO - 10.1016/S0959-8049(97)88064-1

M3 - Article

VL - 33

SP - 1070

EP - 1074

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 7

ER -